Pharma POOL
Mark GLICKMAN
Oscient Promotes Sales Executive Commercial stage pharmaceutical company Oscient Pharmaceuticals, Waltham, Mass., has promoted Mark Glickman to senior VP, sales and marketing, and corporate officer. Since joining Oscient in August 2007 as VP of sales, Mr. Glickman has been instrumental in the growth of the company’s lead product, the high cholesterol therapy Antara. Mr. Glickman received a B.A. in political science from the State University of New York at Oswego and an MBA from New York University. Quentin ROACH BMS Appoints Procurement Chief Quentin Roach has joined Bristol Myers Squibb, New York, as senior VP and chief procurement officer as part of the global pharmaceutical company’s transition to a next generation biopharma model. Mr. Roach is responsible for global leader ship for supplier relationship management, company wide sourcing strategies, and procurement of all materials and services. Mr. Roach was most recently with Bausch & Lomb, where he served as VP, global customer strategy and process management. He also led Bausch & Lomb’s global customer strategy steering committee. He received a B.S. in industrial engineering from Purdue University, as well as an M.S. in engineering from Arizona State University. Biotechnology POOL Frances HELLER Exelixis Appoints Business Development VP Frances Heller has joined Exelixis as executive VP of business development. Exelixis, South San Francisco, Calif., is a development stage biotechnology company focused on novel small molecule therapeutics for the treatment of cancer and other serious diseases. Ms. Heller was most recently head of strategic alliances at Novartis Institutes for Biomedical Research. She received a B.S. in biology from Tulane University, an M.A. in biology from American University, and a J.D. from Golden Gate University School of Law. Daniel JUNIUS Dr. John LAMBERT ImmunoGen Promotes Senior Managers ImmunoGen, Waltham, Mass., a biotechnology company that develops targeted anti cancer products, has promoted Daniel Junius to president and chief operating officer, from his previous role as executive VP and chief financial officer. Mr. Junius joined ImmunoGen in May 2005 as senior VP, finance, and CFO. He received a master’s in management from Northwestern University’s Kellogg School of Management. John Lambert, Ph.D., has been promoted to executive VP, research and development, and chief scientific officer, from senior VP, research and development, and chief scientific officer. Dr. Lambert has been with ImmunoGen since 1987. He received a doctorate in biochemistry from the University of Cambridge. TALENT POOL EXECUTIVE APPOINTMENTS AND PROMOTIONS IN THE HEALTHCARE INDUSTRY Dr. David MAZZO Regado Appoints CEO David Mazzo, Ph.D., has joined Regado Bio sciences as president and CEO, replacing Regado cofounder Douglas Gooding. A spinout of the Department of Surgery at Duke University Medical Center, Regado, Durham, N.C., is a biopharmaceutical company. Dr. Mazzo most recently was president and CEO of AEterna Zentaris. He also has served as president and CEO of Chugai Pharma USA, the U.S. subsidiary of Chugai Pharmaceutical Co. of Japan, a member of the Roche Group. Dr. Mazzo received a B.A. in the honors program (interdisciplinary humanities) and a B.S. in chemistry, both from Villanova University; and an M.S. in chemistry and a Ph.D. in analytical chemistry from the University of Massachusetts. Mark MIRKEN Millennium Biotechnologies Appoints CEO Millennium Biotechnologies, Basking Ridge, N.J., has promoted Mark Mirken to CEO and chairman. Mr. Mirken has served as president and chief operating officer since joining Millennium in September 2007. He replaces Jerry Swon, who has retired to pursue other business interests. Mr. Mirken holds an A.B. from the University of North Carolina and a J.D. from the University of North Carolina School of Law. Millennium Biotechnologies, a wholly owned subsidiary of Millennium Biotechnologies Group, markets advanced nutritional formulas for athletes, cancer patients, and the assisted living community. Dr. Steven SEPE New Medical Chief at RFS Pharma RFS Pharma, Tucker, Ga., has named Steven Sepe, M.D., Ph.D., chief medical officer to head the company’s drug development program. RFS Pharma is a privately owned biotechnology company that develops drugs that combat infections caused by drug resistant HIV and hepatitis viruses. Dr. Sepe previously served as the senior director of medical affairs and medical science liaison for Vertex Pharmaceuticals. He holds an M.D. and a Ph.D. in immunopathology, focusing on the innate immune response, from Boston University. TALENT pool Mark STEJBACH Tengion Names Marketing VP Tengion, an East Norriton, Pa. based clinical stage biotechnology company focused on neoorgans and neotissues, has appointed 20 year industry veteran Mark Stejbach VP, marketing and commercial planning. Mr. Stejbach most recently served as VP of managed care marketing in Merck’s U.S. pharmaceutical division. He received a B.S. in mathematics from Virginia Tech and an MBA from The Wharton School of the University of Pennsylvania. Biopharmaceutical POOL Dr. Martin BEDIGIAN Isis Names Chief Medical Officer Isis Pharmaceuticals has appointed Martin Bedigian, M.D., VP and chief medical officer. Isis, Carlsbad, Calif., uses its expertise in RNA technology to discover and develop novel drugs. Dr. Bedigian was most recently global head of the cardiovascular assessment group at Novartis Pharmaceuticals. He received an M.D. from New York Medical College. Dr. James CARR ARCA Selects Marketing VP ARCA biopharma, Broomfield, Colo., a biopharmaceutical company developing therapies for heart failure and other cardiovascular diseases, has appointed James Carr, Pharm.D., VP of marketing. He executes marketing programs to support ARCA’s lead product candidate, the heart failure medicine Gencaro. He joins ARCA from Anesiva, where he served as VP of marketing for pain management products. Dr. Carr earned a doctor of pharmacy from the University of Minnesota. Joseph DEPINTO ImClone Names Operations VP ImClone Systems, a New York based biopharmaceutical company focused on the development and commercialization of novel anti bodies to treat cancer, has appointed Joseph DePinto VP, commercial operations. Mr. DePinto most recently served as glob al marketing leader, oncology therapeutics, at Johnson & Johnson Pharmaceutical Services. Mr. DePinto holds a B.S. in marketing and an MBA in pharmaceutical chemical studies, both from Fairleigh Dickinson University. Dr. Elkan GAMZU Epix Pharmaceuticals Appoints Interim CEO Epix Pharmaceuticals, Lexington, Mass., a biopharmaceutical company focused on discovering and developing novel therapeutics using its insilico drug discovery plat form, has named Elkan Gamzu, Ph.D., interim CEO following the resignation of Michael Kauffman, Ph.D., to pursue other opportunities. In this role, Dr. Gamzu is working closely with the Epix leadership team to ensure regulatory and clinical continuity of the company’s discovery and development programs. Dr. Gamzu has served as a consultant to the biotechnology and pharmaceutical industries and has held a number of senior executive positions in those industries, including the role of CEO at Pharmos Corp. and Cambridge Neuroscience. He is a graduate of Hebrew University in Jerusalem and obtained M.A. and Ph.D. degrees in experimental and physiological psychology from the University of Pennsylvania. Dr. Randall MOREADITH Nektar Therapeutics Appoints Development Chief Nektar Therapeutics, San Carlos, Calif., has named Randall Moreadith, M.D., Ph.D., senior VP of drug development and chief development officer. Nektar is a biopharmaceutical company. Dr. Moreadith was most recently executive VP and chief medical officer at Cardium Therapeutics. He received an M.D. from Duke University and a Ph.D. from The Johns Hopkins University. Dr. Stefan RYSER Telik Appoints Corporate Strategy VP Telik has appointed Stefan Ryser, Ph.D., to the newly created position of senior VP, corporate strategy. The Palo Alto, Calif., biopharmaceutical company is focused on discovering, developing, and commercializing novel small molecule drugs. Dr. Ryser most recently served as founding and managing partner of Bear Stearns Health Innoventures. Suzanne SENSABAUGH Panacea Hires Regulatory VP Panacea Pharmaceuticals, Gaithersburg, Md., has appointed Suzanne Sensabaugh VP, regulatory affairs, as the privately held biopharmaceutical company prepares to file applications for approval of its prostate and lung cancer diagnostic tests. Ms. Sensabaugh has more than 10 years of experience with the FDA’s Center for Biologics Evaluation and Research as a researcher, product reviewer, and inspector for biologics. Most recently, she served as VP, biopharmaceutical development, at MDS Pharma Services. Ms. Sensabaugh received a B.S. in zoology from the University of Maryland, an M.S. in biotechnology from The Johns Hopkins University, and an MBA from Duke University. Dr. David STAMLER New Medical Chief at XenoPort David Stamler, M.D., has joined XenoPort as senior VP and chief medical officer. XenoPort, Santa Clara, Calif., is a biopharmaceutical company focused on developing products that use the body’s natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. Dr. Stamler has more than 15 years of clinical development experience, most recently as the chief scientific officer and head of drug development for Prestwick Pharmaceuticals. He received a B.A. and M.D. from the University of Chicago. Specialty POOL Al ALTOMARI Jeffrey FRICK Agile Strengthens Leadership Al Altomari has been appointed chairman of Agile Therapeutics, Princeton, N.J., a privately held specialty company focused on women’s healthcare products. Mr. Altomari was previously CEO of Barrier Therapeutics, which has been acquired by Stiefel Laboratories. He earned a B.S. with a dual major in finance and accounting from Drexel University and an MBA from Rider University. In other moves, Agile has named Jeffrey Frick chief business officer. His responsibilities include leading the commercialization of Agile’s low dose contraceptive patch and working with Agile’s leadership team to prioritize and expand the company’s product pipeline. Mr. Frick has more than 20 years of pharmaceutical industry and healthcare agency experience, including marketing experience in women’s health at Berlex and Schering AG. Susan KOPPY Terrence MOORE Transcept Adds New VPs Transcept Pharmaceuticals, a Richmond, Calif.based specialty pharmaceutical company focused on deriving significant new patient benefits from existing CNS drugs, has added two executives to its leadership team. Susan Koppy has been appointed VP, corporate development. Ms. Koppy was most recently senior VP, business and corporate development, at Idenix Pharmaceuticals. She holds a bachelor’s degree in genetics and cell biology from the University of Minnesota. Terrence Moore has joined Transcept as VP, marketing and sales. Mr. Moore previously served as VP of the neuroscience therapeutic area for Organon Biosciences, where he was responsible for the creation and building of the neuroscience business unit. He received a B.S. in pharmacy from the University of Florida and a B.A. in chemistry from the University of South Florida. John KRAYACICH Former Novartis Executive Joins Marinus as CEO Marinus Pharmaceuticals, Branford, Conn., a privately held developer of specialty therapeutics to treat serious neurological, psychiatric, and pain disorders, has appointed John Krayacich as president and CEO. Mr. Krayacich has more than 20 years of experience in pharmaceutical product development, with 13 years focused on neuroscience diseases. He joins Marinus from Novartis Pharmaceuticals, where he most recently served as global program head for the antidepressant agomelatine, and VP and global head of neuroscience project management. Dr. Joel LIPPMAN Anthony VENDITTI Noven Expands Executive Team Noven Pharmaceuticals, a Miami based specialty pharmaceutical company with expertise in transdermal drug delivery focused on psychiatry and women’s health, has added two industry veterans to its leadership team. Joel Lippman, M.D., has joined Noven as VP, clinical development, and chief medical officer. Dr. Lippman is a board certified obstetrician gynecologist. He most recently served as worldwide VP, medical affairs, and chief medical officer at Ethicon. Dr. Lippman received an M.D. from New York Medical College and an MPH from Har vard School of Public Health. Noven has named Anthony Venditti VP, marketing and sales, with responsibility for leading all aspects of the marketing and sales functions at Noven Therapeutics, the company’s specialty pharmaceutical business unit, and Novogyne Pharmaceuticals, the company’s joint venture with Novartis Pharmaceuticals. Mr. Venditti most recently was VP and head of Novartis’ U.S. neuroscience division. Richard PASCOE Somaxon Pharmaceuticals Selects CEO Somaxon Pharmaceuticals has appointed Richard Pascoe president and CEO, succeeding interim CEO David Hale, who continues as Somaxon’s executive chairman. Somaxon, San Diego, is a specialty pharmaceutical company focused on products in the fields of psychiatry and neurology. Mr. Pascoe was previously senior VP and chief operating officer at Ariad Pharmaceuticals. He received a B.S. in leadership studies from the United States Military Academy at West Point. Ronald PRENTKI A.P. Pharma Appoints CEO A.P. Pharma, a Redwood City, Calif. based specialty pharmaceutical company focused on developing pharmaceuticals using its proprietary polymer based drug delivery systems, has appointed Ronald Prentki president and CEO. Mr. Prentki joins A.P. Pharma from Easton Healthcare Ventures, a business development and consulting company he founded in 2005. He received an undergraduate degree in microbiology and public health from Michigan State University and an MBA from the University of Detroit. Emerging POOL Dr. Abbie CELNIKER Taligen Opens Massachusetts Headquarters As part of its corporate growth plan, Tali gen Therapeutics has named Abbie Celniker, Ph.D., as CEO and established its headquarters in Cambridge, Mass. Dr. Celniker succeeds Taligen co founder Woodruff Emlen, M.D., who remains president of the company. Taligen is focused on the discovery and development of novel protein therapeutics designed to treat a wide range of inflammatory conditions and diseases. Dr. Celniker was previously global head of Novartis Biologics. She received a B.A. in biology from the University of California, San Diego, and a Ph.D. in molecular biology from the University of Arizona. Dr. Sandra PALLEJA Dr. Jay RHEINGOLD Angeline SHASHLO Tobira Forms Management Team Tobira Therapeutics, a privately held clinical stage biotechnology company focused on infectious diseases, has made several appointments. Tobira has named Sandra Palleja, M.D., executive VP and chief medical officer. Ms. Palleja most recently was VP of clinical development at Shionogi USA. She earned her M.D. from Boston University School of Medicine. Jay Rheingold, Ph.D., has joined Tobira as VP, chemistry manufacturing and controls. Dr. Rheingold was VP at Barrier Therapeutics. He received a doctorate in pharmaceutical sciences from the University of Connecticut. Angeline Shashlo, R.Ph., has been appointed senior VP, regulatory affairs and quality assurance. Ms. Shashlo was previously VP of regulatory affairs and quality assurance at Incyte. She received a B.S. in pharmacy from the University of Michigan. Association POOL Dr. Derek WINSTANLY ACRO Taps Quintiles VP as Chair Elect Derek Winstanly, MBChB, executive VP of strategic business partner ships at Quintiles Transnational, has been appointed 2008 chair elect of the Association of Clinical Research Organi zations, the Washington, D.C.based organization of companies whose focus is clinical research. Dr. Winstanly assumes the chairmanship in 2009. Agency POOL Jennifer Sharp BEAUMONT Michael CHRISTOV Lynnette HUNTER Sarah JENKINS Emilee LALES AbelsonTaylor Makes promotions Independent health care advertising agency Abel onTaylor, Chicago, has announced several promotions and hires. Jennifer Sharp Beaumont has been promoted to account supervisor from senior account executive. Ms. Beaumont works on products in the oncology category. She graduated magna cum laude with a B.A. in journalism from the University of Missouri. Michael Christov has joined AbelsonTaylor as senior account supervisor working on accounts in the diabetes care area. Mr. Christov was previously senior marketing manager at Baxter Healthcare. He received a B.A. in German and international studies from San Francisco State University, an M.S. in engineering from the University of Darmstadt in Germany, and an MBA specializing in strategic management and international marketing from Indiana University’s Kelley School of Business. Lynnette Hunter has been promoted to account supervisor, with responsibility for diabetes prod ucts. Previously, Ms. Hunter managed an insomnia product. She earned a B.S. in biological sciences from the Univer sity of Illinois. Sarah Jenkins, previously senior account executive, has been promoted to account supervisor for an account in the insomnia category. She has a B.S. in business administration from the University of Illinois at Urbana Champaign. Emilee Lales has been promoted to senior account executive from account executive. She works on accounts in the cardiovascular category. She holds a B.A. in human development from the University of Chicago. Ann CALANDRO David CRUZ Phuong HUYNH Lan LUONG Jason MILLER Ignite Health Adds Staff in N.J., California Offices Ignite Health, an inVentiv Health company and marketing agency that specializes in patient centered technology driven medical advertising, has named Ann Calandro senior editor in its Somerset, N.J., office. Ms. Calandro was previously medical editor at MRM Gillespie. She received a master’s degree from Washington University. David Cruz has joined Ignite’s Irvine, Calif., staff as Web analyst. Mr. Cruz previous ly held the same position at RealtyTrac. He received a bachelor’s degree from the University of California. Also in Irvine, Phuong Huynh has been named Web analytics implementation manager. Mr. Huynh most recently worked for California State University’s Office of the Chancellor as Web coordinator. He earned a master’s degree from Loma Linda University. Lan Luong has been appointed senior art director in the Irvine office. Ms. Luong previ ously served as senior graphic designer for VPI.Net. She holds a bachelor’s degree from the School of Design at George Brown College in Toronto. Jason Miller has joined the Irvine office as Web developer. Mr. Miller was most recently digital file support for FarHeap Solutions. Julie DEEL Navicor Adds Account Director The Navicor Group, a Columbus, Ohio based healthcare advertising agency specializing in oncology and immunology, has hired Julie Deel as account director. Navicor is an inVentiv Health company. Ms. Deel previously held the same position at Complete Healthcare Communications. She received a bachelor’s degree from the University of Kentucky. John DRAPER NewVP at Peloton John Draper, MBA, has joined Peloton Advantage as senior VP, health care manage ment. Peloton, Parsippany, N.J., is a privately owned medical communications company specializing in strategic publication planning. Previously, Mr. Draper served as VP, strategic planning and managed markets at Cardinal Health. He received a B.A. in psychology and economics from Connecticut College and an MBA from the Whittemore School of Business & Economics at the University of New Hampshire. Michel DUPUIS S&H Appoints Head of Montreal Office Global communications agency Sudler & Hennessey, New York, has named Michel Dupuis managing director of its Montreal office, with responsibility for strategic and leadership oversight for all medical direction, client services, and promotional and strategic medical education. Mr. Dupuis was previously regional director of nine major markets for IMS Health’s Latin America office. Todd GREENE Cadient Hires Strategic Engagement Director Cadient Group, a Conshohocken, Pa. based strategic interactive marketing agency serving the healthcare industry, has appointed Todd Greene strategic engagement director based in the agency’s New York office. Mr. Greene previously worked for OgilvyOne as management supervisor on health insurance and functional foods initiatives, including the Aflac and Unilever brands. He earned a bachelor’s degree in journalism within an advertising sequence from the University of Missouri’s School of Journalism. Dr. Boris KUSHKULEY New General Manager at Qi Qi, a fullservice digital agency and part of CommonHealth, has promoted Boris Kushkuley, Ph.D., to general manager, from executive VP, chief technology officer. Dr. Kushkuley is responsible for evolving and developing innovative emarketing solutions and strategies in all areas of electronic media, including the Web, CDROM, kiosks, DVDs, and custom applications. Rich LEVY Elise URBAHN Adam WARD GSW Announces Additions to New York Office Healthcare advertising agency GSW Worldwide, an inVentiv Health company, has named Rich Levy executive creative director for the agency’s New York office. Mr. Levy has more than 25 years of advertising experience for a diverse group of global, consumer, and healthcare clients. He most recently served as executive VP, executive creative director, at Ogilvy Healthworld. Elise Urbahn has been named account executive based in GSW’s NewYork office. She wasnpreviously marketing and sales assistant for LifeMed Media. Ms. Urbahn received a bachelor’s degree from Wake Forest University. Adam Ward has joined GSW’s New York office as group copy supervisor, from the same position at Sudler & Hennessey. Mr. Ward received a bachelor’s degree from University College London. Lauren MARSH New Account Executive at Topin & Associates Full service healthcare marketing communications agency Topin & Associates, Chicago, has hired Lauren Marsh as an account executive working on the Ovation and Teva Neuroscience teams. Ms. Marsh was previously an account manager at Discovery Chicago. Susan MCNAIRMARONEY MedPoint Hires Account Director MedPoint Communications, an Evanston, Ill. based provider of communications and emedia services, has named Susan McNair Maroney account director. Ms. McNair Maroney most recently served as director of sales at MediMedia USA. She received a bachelor’s degree in communications from Seton Hall University. Liza MORRIS Spectrum Science Promotes Company Veteran Full service agency Spectrum Science Communications, Washington, D.C., has promoted Liza Morris to senior VP. Ms. Morris continues to oversee several corporate and nonprofit accounts while providing agency leadership on measurement and performance metrics. She also plays a key role in the agency’s future growth and market expansion. Craig MURRAY Melissa PERTICARI Erik STERNBERGER Blue Diesel Announces New Hires Interactive communications agency Blue Diesel, an inVentiv Health company, has made a number of additions to its offices in Columbus, Ohio, and Newtown, Pa. Craig Murray has been named interactive art director for the Columbus office. Mr. Murray most recently served as owner and creative director for CAM Design. He received a bach elor’s degree from Bowling Green State University. Melissa Perticari has joined Blue Diesel’s Newtown office as account manager from the same position at Digitas Health. She holds a bachelor’s degree from Rutgers University. In the Columbus office, Erik Sternberger has been named senior multimedia developer. Previously, Mr. Sternberger served as lead flash developer for LaBov & Beyond. He earned a bachelor’s degree from Purdue University. Jennifer PETERS Goble Strengthens Account Group Leadership Healthcare communications agency Goble & Associates, Chicago, has hired Jennifer Peters as executive VP, account group director. Ms. Peter previously served as senior VP, group account director, for GSW Worldwide. She received a B.A. in journalism from Indiana University. Jennifer PROSEK Cadent Adds to Account Team Cadent Medical Communications, an Irvine, Texas, company specializing in medical education and communications, has appointed Jennifer Prosek account executive. Cadent is an inVentiv Health company. Ms. Prosek most recently worked for ProEd Communications as account coordinator. She received a bachelor’s degree from the University of Toledo. Christine STUDENT Arista Marketing Taps Managing Director Arista Marketing Associates, Blue Bell, Pa., has promoted Christine Student to managing director from her previous position of senior VP of operations. Arista Marketing, a Publicis Healthcare Communications Group company, provides field alternative messaging services for biopharma. In her new role, Ms. Student has responsibility for the company’s day to day operations and longterm strategic planning. Consulting POOL Nader NAEYMIRAD Darius NAIGAMWALLA Campbell Alliance Promotes Campbell Alliance, Raleigh, N.C., a management consulting firm, has promoted company veteran Nader NaeymiRad to the role of chief operating officer. Mr. NaeymiRad has been with Campbell since the firm’s founding in 1997. His previous role as Campbell’s senior VP and head of the brand management practice has been assumed by Darius Naigamwalla, who has been a member of the practice since joining Campbell Alliance in 2001. Mr. Naigamwalla oversees the brand management practice’s operations in North America, the United Kingdom, and Europe. He earned a B.S. with honors from McMaster University in Hamilton, Ontario; an M.S. in biochemistry and molecular biology from the University of Western Ontario; and an MBA from the University of Victoria in Victoria, British Columbia. CRO POOL Dr. Christine DINGIVAN New Medical Chief at PPD PPD, Wilmington, N.C., has named Christine Dingivan, M.D., executive VP and chief medical officer. Dr. Dingivan spent 12 years with MedImmune, most recently as senior VP of clinical development and opera tions. She earned an undergraduate degree in bioengineering from the University of Pennsylvania and a medical degree from Dart mouth Medical School. Dr. Mark GOLDBERG Parexel Promotes Officer Parexel International, Waltham, Mass., has promoted Mark Goldberg, M.D., to chief operating officer, from president of clinical research services and Perceptive Informatics. He holds a degree in computer science and engineering from the Massachusetts Institute of Technology and an M.D. from the University of Massachusetts Medical School. Tami KLERRNAIVAR PRA Hires Business Development VP PRA International, Raleigh, N.C., has named Tami KlerrNaivar senior VP of business development and head of PRA’s global business development organization. Ms. KlerrNaivar joins PRA from InfaCare Pharmaceutical, where she served as VP of clinical operations. She received a B.S. in biology from the University of Pennsylvania. Dr. David SUBICH INC Research Taps Head of Metabolic, Endocrine Operations INC Research, Raleigh, N.C., has appointed David Subich, M.D., senior director, clinical operations for metabolic and endocrine diseases. Dr. Subich has 23 years of experience as an attending physician specializing in internal medicine with a focus on metabolic and endocrine diseases. Dr. Subich received his medical degree from the Medical College of Ohio. Medical Education POOL Mary ANDERSON HLS Names New President HLS, Parsippany, N.J., the founding Common Health medical education unit, has promoted Mary Anderson to president from general manager. Ms. Anderson has primary responsibility for HLS and is charged with innovating program offerings to meet changes in the healthcare environment. Service POOL Penny COLBY Stephanie DRIVER Marianne NUGENT Total Learning Concepts Adds Staff in Wake of N.J. Move Total Learning Concepts, a training content company that specializes in elearning, has made a number of promotions and additions to its staff following the recent relocation of the company to Lawrenceville, N.J., from Boston. Total Learning Concepts is a Publicis Healthcare Communications Group company. Penny Colby has been hired as a project manager. Ms. Colby was previously a product manager at G2X. Stephanie Driver has been promoted to senior project manager from project manager. Marianne Nugent has been promoted to senior director of strategic initiatives. This is a transfer for Ms. Nugent, who was previously a director for Publicis Managed Markets. Susan DRISCOLL Wolters Kluwer Health Strengthens Books Division Wolters Kluwer Health has named Susan Driscoll executive VP and general manager of the books division of its professional and education business unit based in the company’s Philadelphia office. Wolters Kluwer Health, Conshohocken, Pa., a division of Wolters Kluwer, provides information and business intelligence to medical and pharmaceutical companies and institutions. Ms. Driscoll’s previous roles include VP, strategy, for Author Solutions and president and CEO of iUniverse. She received a BFA from the University of Notre Dame. George FOTIADES Catalent Names Interim CEO Catalent Pharma Solutions has appointed Chairman George Fotiades interim president and CEO, replacing John Lowry, who has left Catalent to pursue other opportunities. Catalent, Somerset, N.J., provides advanced technologies and development, manufacturing, and packaging services for pharmaceutical, biotechnology, and consumer healthcare companies worldwide. Dr. Michael GIULIANI Dr. Ralph HEASLEY Dr. James YOUNG Covidien Names Executives Covidien, St. Louis, the independent provider of healthcare products formerly known as Tyco Healthcare, has appointed its research and development leadership team. Michael Giuliani, M.D., has joined Covidien as VP of R&D for pharmaceutical products and imaging solutions. Dr. Giuliani was previously chief medical officer and executive VP of product development at Xanodyne Pharmaceuticals. He received a bachelor’s degree in biology from Tulane University and a medical degree from The Ohio State University College of Medicine. Ralph Heasley, Ph.D., has been appointed VP of global R&D technology, pharmaceutical products. Dr. Heasley has more than 30 years of experience in pharmaceutical R&D. He earned a bachelor’s degree in chemistry from Ottawa University, a master’s degree in business from the University of Minnesota, and a doctorate in physical chemistry from the University of Kansas. James Young, Ph.D., has been named VP of R&D operations for pharmaceutical products and imaging solutions. Dr. Young was most recently VP of product development at Xanodyne Pharmaceuticals. He earned a bachelor’s degree in genetic biology from Purdue University and a doctorate in molecular genetics from The Ohio State University. Nandini HADKER Abt BioPharma Promotes Abt BioPharma Solutions (ABS), a Lexington, Mass. based provider of integrated clinical, health economic, and strategic commercialization solutions, has promoted Nandini Hadker to executive director. Ms. Hadker succeeds Susan WindhamBannister, Ph.D., who has been appointed president and CEO of the Massachusetts Life Sciences Center. Ms. Hadker holds a master’s degree in economics from Boston University. Meaghan ONOFREY MBS/Vox Promotes Linguistic Expert to President Meaghan Onofrey has been promoted to president of MBS/Vox, Parsippany, N.J., the research consultancy unit of CommonHealth that specializes in the analysis of healthcare interactions, including inoffice physician patient dialogue. Ms. Onofrey was previously the company’s general manager. Ms. Onofrey holds a bachelor’s degree in linguistics and a master’s degree in sociolinguistics, both from Georgetown University. Terek PETERSON Octagon Hires Clinical Programming Director Octagon Research Solutions, a Wayne, Pa. based provider of software and services to the lifesciences industry, has appointed of Terek Peterson, MBA, as director, clinical programming. Before joining Octagon, he served as senior manager, statistical programming global biometrics, for Shire. Dan RUBIN Norman STALSBERG inVentiv Health Appoints Division Heads inVentiv Health, Columbus, Ohio, has named Dan Rubin president of inVentiv Patient Outcomes. Previously, Mr. Rubin served as CEO and cofounder of Adheris, a patient compliance company that inVentiv acquired in 2006. Other companies within the division include AWAC, The Franklin Group, and The Therapeutics Institute. Norman Stalsberg has been appointed president of inVentiv Strategy & Analytics, a division of inVentiv Commercial. Mr. Stalsberg was most recently president of CHS, a Strategy & Analytics business that provides outsourced marketing solutions. Other companies within Strategy & Analytics include Health Products Research (HPR), Strategyx, and Ventiv Access Services. Kevin SHARP Publicis Selling Solutions Hires Client Services Director Publicis Selling Solutions, a Lawrenceville, N.J. based provider of sales teams and support services to the biopharmaceutical industry, has appointed Kevin Sharp director of client services. Mr. Sharp was most recently the managing partner for Sharp Pharmaceutical Consulting. Publicis Selling Solutions is a Publicis Healthcare Communications Group company. Technology POOL Marla HOELLE Scott HORTON Jeff OSTERHAUS Statking Consulting Announces Promotion, New Hires Statking Consulting, a Cincinnati based provider of data related services for clinical trials, has promoted Marla Hoelle to director of project management from section head of project management. Ms. Hoelle supervises all clinical study monitoring activities at Statking. A registered nurse, she received a B.S. in nursing from the University of Cincinnati. Scott Horton has joined SCI as director of statistical programming. Mr. Horton led data management activities at three organizations before joining SCI. He holds B.S. and M.S. degrees in statistics from Brigham Young University. Jeff Osterhaus has been named senior contracts manager. He also assists with marketing efforts and various other special projects. Mr. Osterhaus was previously a cost accounting manager and a project financial analyst with Kendle International. He received a B.S. in finance from Miami University. Send your personnel announcements to [email protected].

Download PDF